Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,666,757
+$2,035,006 QoQ
Shares Held
6,392
+4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#1,411
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. LLY ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,392 | $7,666,757 | |
| 2 | AMGN |
Amgen Inc
|
15,803 | $5,722,582 | |
| 3 | JNJ |
Johnson & Johnson
|
19,135 | $4,859,715 | |
| 4 | ABBV |
AbbVie Inc.
|
16,399 | $4,126,644 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,697 | $4,073,064 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,095 | $3,802,202 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49,118 | $2,830,179 | |
| 8 | PFE |
Pfizer Inc
|
52,773 | $1,270,773 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,666,757 | 6,392 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,631,751 | 6,123 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $6,139,647 | 5,713 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,236,176 | 5,552 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,555,573 | 5,844 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,363,282 | 5,283 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $3,856,912 | 4,996 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,365,026 | 4,927 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $4,980,495 | 5,501 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,169,087 | 5,359 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,688,427 | 4,612 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,614,748 | 4,868 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,330,830 | 4,970 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,644,294 | 4,788 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,738,837 | 4,753 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,571,157 | 4,859 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $954,208 | 2,943 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $717,929 | 2,507 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $651,326 | 2,358 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $493,522 | 2,136 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $479,926 | 2,091 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $386,717 | 2,070 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $349,498 | 2,070 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $328,604 | 2,220 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $386,315 | 2,353 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $326,408 | 2,353 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||